Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
24,240,291
-
Share change
-
-8,371,897
-
Total reported value
-
$32,725,157
-
Price per share
-
$1.35
-
Number of holders
-
44
-
Value change
-
-$18,349,949
-
Number of buys
-
26
-
Number of sells
-
29
Institutional Holders of ODONATE THERAPEUTICS INC - COM (ODTC) as of Q4 2021
As of 31 Dec 2021,
ODONATE THERAPEUTICS INC - COM (ODTC) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,240,291 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, BOXER CAPITAL, LLC, Ikarian Capital, LLC, VANGUARD GROUP INC, Samsara BioCapital, LLC, ACADIAN ASSET MANAGEMENT LLC, BlackRock Inc., D. E. Shaw & Co., Inc., GEODE CAPITAL MANAGEMENT, LLC, and MYDA Advisors LLC.
This page lists
44
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.